DK0931264T3 - Fremgangsmåde til diagnosticering af aterosklerose - Google Patents

Fremgangsmåde til diagnosticering af aterosklerose

Info

Publication number
DK0931264T3
DK0931264T3 DK97939603T DK97939603T DK0931264T3 DK 0931264 T3 DK0931264 T3 DK 0931264T3 DK 97939603 T DK97939603 T DK 97939603T DK 97939603 T DK97939603 T DK 97939603T DK 0931264 T3 DK0931264 T3 DK 0931264T3
Authority
DK
Denmark
Prior art keywords
level
atherosclerosis
diagnosing atherosclerosis
chlorotyrosine
inflammation
Prior art date
Application number
DK97939603T
Other languages
Danish (da)
English (en)
Inventor
Jay W Heinecke
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK0931264T3 publication Critical patent/DK0931264T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Hydrogenated Pyridines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
  • Medicines Containing Plant Substances (AREA)
DK97939603T 1996-09-09 1997-09-03 Fremgangsmåde til diagnosticering af aterosklerose DK0931264T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/709,916 US6268220B1 (en) 1996-09-09 1996-09-09 Diagnostic method for atherosclerosis
PCT/US1997/015114 WO1998010294A1 (fr) 1996-09-09 1997-09-03 Procede de diagnostic de l'atherosclerose

Publications (1)

Publication Number Publication Date
DK0931264T3 true DK0931264T3 (da) 2002-08-05

Family

ID=24851820

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97939603T DK0931264T3 (da) 1996-09-09 1997-09-03 Fremgangsmåde til diagnosticering af aterosklerose

Country Status (11)

Country Link
US (1) US6268220B1 (fr)
EP (1) EP0931264B1 (fr)
JP (1) JP3553611B2 (fr)
AT (1) ATE216495T1 (fr)
AU (1) AU4165197A (fr)
CA (1) CA2264757C (fr)
DE (1) DE69712079T2 (fr)
DK (1) DK0931264T3 (fr)
ES (1) ES2175453T3 (fr)
PT (1) PT931264E (fr)
WO (1) WO1998010294A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306576B1 (en) 1999-02-19 2001-10-23 Cleveland Clinic Foundation Diagnostic methods for asthma
US6548252B1 (en) * 2000-10-13 2003-04-15 Esa, Inc. Detection of DNA damage
CA2440978C (fr) 2001-01-02 2013-04-02 The Cleveland Clinic Foundation La myeloperoxydase : un indicateur de risque des maladies cardio-vasculaires
US7780950B2 (en) * 2002-01-02 2010-08-24 The Cleveland Clinic Foundation Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
CA2446962A1 (fr) * 2001-05-09 2002-11-14 Insight Biopharmaceuticals Ltd. Methodes et materiels faisant appel a l'heparanase en tant que marqueur diagnostique pour des troubles hemostatiques
US6939716B2 (en) * 2001-09-19 2005-09-06 Washington University Method for detecting conditions indicative of sepsis
US20060166295A1 (en) * 2002-07-01 2006-07-27 James Woods Method for determination of likelihood of occurrence of preterm labor in pregnant females
US7459286B1 (en) 2003-10-22 2008-12-02 The Cleveland Clinic Foundation Assessing the risk of a major adverse cardiac event in patients with chest pain
JP4625812B2 (ja) 2003-12-05 2011-02-02 ザ クリーブランド クリニック ファウンデーション 心臓血管疾患に対するリスクマーカー
US7749729B2 (en) * 2004-07-19 2010-07-06 University Of Washington Methods for assessing the risk for development of cardiovascular disease
WO2006020498A2 (fr) * 2004-08-11 2006-02-23 The Cleveland Clinic Foundation Agents therapeutiques et procedes associes pour maladies cardiovasculaires
DE102004042530B4 (de) * 2004-09-02 2006-10-19 Mosaiques Diagnostics And Therapeutics Ag Verfahren zur Diagnose von Arteriosklerose
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease
WO2012141737A1 (fr) 2010-10-19 2012-10-18 Battelle Memorial Institute Compositions, anticorps, procédés de diagnostic de l'asthme et procédés de préparation d'anticorps
US9606082B2 (en) 2015-05-11 2017-03-28 The University Of North Carolina At Chapel Hill Pressure driven microfluidic injection for chemical separations
US10734216B2 (en) 2015-05-11 2020-08-04 The University Of North Carolina At Chapel Hill Pressure driven fluidic injection for chemical separations by electrophoresis
US9728387B2 (en) * 2015-10-20 2017-08-08 The University Of North Carolina At Chapel Hill Solid phase extraction with capillary electrophoresis

Also Published As

Publication number Publication date
ATE216495T1 (de) 2002-05-15
PT931264E (pt) 2002-08-30
JP2001500257A (ja) 2001-01-09
AU4165197A (en) 1998-03-26
EP0931264B1 (fr) 2002-04-17
ES2175453T3 (es) 2002-11-16
DE69712079T2 (de) 2002-10-02
US6268220B1 (en) 2001-07-31
DE69712079D1 (de) 2002-05-23
EP0931264A1 (fr) 1999-07-28
JP3553611B2 (ja) 2004-08-11
CA2264757A1 (fr) 1998-03-12
WO1998010294A1 (fr) 1998-03-12
CA2264757C (fr) 2005-10-04

Similar Documents

Publication Publication Date Title
DK0931264T3 (da) Fremgangsmåde til diagnosticering af aterosklerose
DK0931265T3 (da) Diagnistisk metode for aterosklerose
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
DE69736527D1 (de) Messvorrichtung zur schnellen nichtinvasiven blutdruckbestimmung
AU1726797A (en) A method for monitoring the health of a patient by measuring and predicting the glucose level of the patient's blood sample
EE9700163A (et) Diagnostiline testkandja, selle kasutamine ja meetod vedeliku analüüdi määramiseks
NO971348D0 (no) Pröveenhet for oppsamling og undersökelse av kroppsvæske
DE69727998D1 (de) Optimaler Diagnosepunktdetektor für nichtinvasive Diagnose von Blutbestandteile
DE69937368D1 (de) Nachweis von erkrankungen der nieren und behandlung
DE69903898T2 (de) Teststreifen zur visuellen Ermittlung der Blutglukose-Konzentration
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
DE69732223D1 (de) Ultraschall-Echographiesystem zur Untersuchung von Arterien
ES2194116T3 (es) Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona.
EP0924523A3 (fr) Méthode et moyens diagnostiques pour la détection des désordres hémostatiques
AU2634595A (en) A diagnostic method for establishing food intolerance/allergy, and an instrument for use when carrying out the method
DE60037676D1 (de) Verfahren zur diagnose von rickettsia pulicis
DE68911574T2 (de) Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür.
ATE220458T1 (de) Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten
IT1276615B1 (it) Metodo per la rivelazione di catecolamine durante il ritmo circadiano, uso di detto metodo per la diagnosi e la terapia di malattie nervose
RU2000105525A (ru) Способ оценки степени тяжести интоксикации у детей с гнойно-септическими заболеваниями
NO974679D0 (no) Fremgangsmåte og forsökssett for diagnostikk og for bestemmelse av risiko for progresjon derav
DE69522935T2 (de) Verfahren zur Erfassung der Geschwindigkeit von Gewebe oder Blut und Ultraschall-Diagnosevorrichtung